Cargando…
The burden of diabetes and hyperglycemia in Brazil-past and present: findings from the Global Burden of Disease Study 2015
BACKGROUND: Diabetes, hyperglycemia, and their complications are a growing problem in Brazil. However, no comprehensive picture of this disease burden has yet been presented to date. METHODS: We used Global Burden of Disease 2015 data to characterize diabetes prevalence, incidence and risk factors f...
Autores principales: | , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5348777/ https://www.ncbi.nlm.nih.gov/pubmed/28293304 http://dx.doi.org/10.1186/s13098-017-0216-2 |
_version_ | 1782514319798304768 |
---|---|
author | Duncan, Bruce Bartholow Schmidt, Maria Inês Ewerton Cousin Moradi-Lakeh, Maziar Passos, Valéria Maria de Azeredo França, Elisabeth Barboza Marinho, Fátima Mokdad, Ali H. |
author_facet | Duncan, Bruce Bartholow Schmidt, Maria Inês Ewerton Cousin Moradi-Lakeh, Maziar Passos, Valéria Maria de Azeredo França, Elisabeth Barboza Marinho, Fátima Mokdad, Ali H. |
author_sort | Duncan, Bruce Bartholow |
collection | PubMed |
description | BACKGROUND: Diabetes, hyperglycemia, and their complications are a growing problem in Brazil. However, no comprehensive picture of this disease burden has yet been presented to date. METHODS: We used Global Burden of Disease 2015 data to characterize diabetes prevalence, incidence and risk factors from 1990 to 2015 in Brazil. Additionally, we provide mortality, years of life lost prematurely (YLL), years of life lived with disability (YLD) and disability-adjusted life years (DALYs) lost due to diabetes, as well as similar data for chronic kidney disease (CKD) due to diabetes and, as an overall summary measure, for hyperglycemia, the latter expressed as high fasting plasma glucose (HFPG). RESULTS: From 1990 to 2015 diabetes prevalence rose from around 3.6 to 6.1%, and YLLs, YLDs, and DALYs attributable to diabetes increased steadily. The crude diabetes death rate increased 90% while that of CKD due to diabetes more than doubled. In 2015, HFPG became Brazil’s 4th leading cause of disability, responsible for 65% of CKD, for 7.0% of all disability and for the staggering annual loss of 4,049,510 DALYs. Diabetes DALYs increased by 118.6% during the period, increasing 42% due to growth in Brazil´s population, 72.1% due to population ageing, and 4.6% due to the change in the underlying, age-standardized rate of DALY due to diabetes. Main risk factors for diabetes were high body mass index; a series of dietary factors, most notably low intake of whole grains and of nuts and seeds, and high intake of processed meats; low physical activity and tobacco use, in that order. CONCLUSIONS: Our study demonstrates that diabetes, CKD due to diabetes, and hyperglycemia produce a large and increasing burden in Brazil. These findings call for renewed efforts to control the joint epidemics of obesity and diabetes, and to develop strategies to deal with the ever-increasing burden resulting from these diseases. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (doi:10.1186/s13098-017-0216-2) contains supplementary material, which is available to authorized users. |
format | Online Article Text |
id | pubmed-5348777 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2017 |
publisher | BioMed Central |
record_format | MEDLINE/PubMed |
spelling | pubmed-53487772017-03-14 The burden of diabetes and hyperglycemia in Brazil-past and present: findings from the Global Burden of Disease Study 2015 Duncan, Bruce Bartholow Schmidt, Maria Inês Ewerton Cousin Moradi-Lakeh, Maziar Passos, Valéria Maria de Azeredo França, Elisabeth Barboza Marinho, Fátima Mokdad, Ali H. Diabetol Metab Syndr Research BACKGROUND: Diabetes, hyperglycemia, and their complications are a growing problem in Brazil. However, no comprehensive picture of this disease burden has yet been presented to date. METHODS: We used Global Burden of Disease 2015 data to characterize diabetes prevalence, incidence and risk factors from 1990 to 2015 in Brazil. Additionally, we provide mortality, years of life lost prematurely (YLL), years of life lived with disability (YLD) and disability-adjusted life years (DALYs) lost due to diabetes, as well as similar data for chronic kidney disease (CKD) due to diabetes and, as an overall summary measure, for hyperglycemia, the latter expressed as high fasting plasma glucose (HFPG). RESULTS: From 1990 to 2015 diabetes prevalence rose from around 3.6 to 6.1%, and YLLs, YLDs, and DALYs attributable to diabetes increased steadily. The crude diabetes death rate increased 90% while that of CKD due to diabetes more than doubled. In 2015, HFPG became Brazil’s 4th leading cause of disability, responsible for 65% of CKD, for 7.0% of all disability and for the staggering annual loss of 4,049,510 DALYs. Diabetes DALYs increased by 118.6% during the period, increasing 42% due to growth in Brazil´s population, 72.1% due to population ageing, and 4.6% due to the change in the underlying, age-standardized rate of DALY due to diabetes. Main risk factors for diabetes were high body mass index; a series of dietary factors, most notably low intake of whole grains and of nuts and seeds, and high intake of processed meats; low physical activity and tobacco use, in that order. CONCLUSIONS: Our study demonstrates that diabetes, CKD due to diabetes, and hyperglycemia produce a large and increasing burden in Brazil. These findings call for renewed efforts to control the joint epidemics of obesity and diabetes, and to develop strategies to deal with the ever-increasing burden resulting from these diseases. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (doi:10.1186/s13098-017-0216-2) contains supplementary material, which is available to authorized users. BioMed Central 2017-03-14 /pmc/articles/PMC5348777/ /pubmed/28293304 http://dx.doi.org/10.1186/s13098-017-0216-2 Text en © The Author(s) 2017 Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated. |
spellingShingle | Research Duncan, Bruce Bartholow Schmidt, Maria Inês Ewerton Cousin Moradi-Lakeh, Maziar Passos, Valéria Maria de Azeredo França, Elisabeth Barboza Marinho, Fátima Mokdad, Ali H. The burden of diabetes and hyperglycemia in Brazil-past and present: findings from the Global Burden of Disease Study 2015 |
title | The burden of diabetes and hyperglycemia in Brazil-past and present: findings from the Global Burden of Disease Study 2015 |
title_full | The burden of diabetes and hyperglycemia in Brazil-past and present: findings from the Global Burden of Disease Study 2015 |
title_fullStr | The burden of diabetes and hyperglycemia in Brazil-past and present: findings from the Global Burden of Disease Study 2015 |
title_full_unstemmed | The burden of diabetes and hyperglycemia in Brazil-past and present: findings from the Global Burden of Disease Study 2015 |
title_short | The burden of diabetes and hyperglycemia in Brazil-past and present: findings from the Global Burden of Disease Study 2015 |
title_sort | burden of diabetes and hyperglycemia in brazil-past and present: findings from the global burden of disease study 2015 |
topic | Research |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5348777/ https://www.ncbi.nlm.nih.gov/pubmed/28293304 http://dx.doi.org/10.1186/s13098-017-0216-2 |
work_keys_str_mv | AT duncanbrucebartholow theburdenofdiabetesandhyperglycemiainbrazilpastandpresentfindingsfromtheglobalburdenofdiseasestudy2015 AT schmidtmariaines theburdenofdiabetesandhyperglycemiainbrazilpastandpresentfindingsfromtheglobalburdenofdiseasestudy2015 AT ewertoncousin theburdenofdiabetesandhyperglycemiainbrazilpastandpresentfindingsfromtheglobalburdenofdiseasestudy2015 AT moradilakehmaziar theburdenofdiabetesandhyperglycemiainbrazilpastandpresentfindingsfromtheglobalburdenofdiseasestudy2015 AT passosvaleriamariadeazeredo theburdenofdiabetesandhyperglycemiainbrazilpastandpresentfindingsfromtheglobalburdenofdiseasestudy2015 AT francaelisabethbarboza theburdenofdiabetesandhyperglycemiainbrazilpastandpresentfindingsfromtheglobalburdenofdiseasestudy2015 AT marinhofatima theburdenofdiabetesandhyperglycemiainbrazilpastandpresentfindingsfromtheglobalburdenofdiseasestudy2015 AT mokdadalih theburdenofdiabetesandhyperglycemiainbrazilpastandpresentfindingsfromtheglobalburdenofdiseasestudy2015 AT duncanbrucebartholow burdenofdiabetesandhyperglycemiainbrazilpastandpresentfindingsfromtheglobalburdenofdiseasestudy2015 AT schmidtmariaines burdenofdiabetesandhyperglycemiainbrazilpastandpresentfindingsfromtheglobalburdenofdiseasestudy2015 AT ewertoncousin burdenofdiabetesandhyperglycemiainbrazilpastandpresentfindingsfromtheglobalburdenofdiseasestudy2015 AT moradilakehmaziar burdenofdiabetesandhyperglycemiainbrazilpastandpresentfindingsfromtheglobalburdenofdiseasestudy2015 AT passosvaleriamariadeazeredo burdenofdiabetesandhyperglycemiainbrazilpastandpresentfindingsfromtheglobalburdenofdiseasestudy2015 AT francaelisabethbarboza burdenofdiabetesandhyperglycemiainbrazilpastandpresentfindingsfromtheglobalburdenofdiseasestudy2015 AT marinhofatima burdenofdiabetesandhyperglycemiainbrazilpastandpresentfindingsfromtheglobalburdenofdiseasestudy2015 AT mokdadalih burdenofdiabetesandhyperglycemiainbrazilpastandpresentfindingsfromtheglobalburdenofdiseasestudy2015 |